Alembic Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr. Saibal Mukherjee, Resident Director (Delhi Office) of the company on April 26, 2026.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic Pharmaceuticals has announced the passing of Mr. Saibal Mukherjee, Resident Director at their Delhi Office, who died on April 26, 2026. He had been with the company since 2014, making his tenure approximately 12 years. The company described his death as a sudden and unexpected event that will be an irreparable loss. The filing was made under SEBI's Regulation 30 for disclosure of material events. The company expressed condolences to his family on behalf of all directors and employees. No immediate details about succession or replacement were provided in this announcement.
This is a neutral-to-minor negative development as the company loses a long-tenured management professional. There is no direct impact on financials, but the departure creates a vacancy in the Delhi Office leadership that the company will need to address.